Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan

INTRODUCTION: Percutaneous hepatic perfusion (PHP) with melphalan is an effective treatment for patients with hepatic metastases, but associated with high rates of bone marrow depression. To reduce systemic toxicity, improvements have been made to the filtration system. In pre-clinical studies, the...

Descripción completa

Detalles Bibliográficos
Autores principales: de Leede, Eleonora M., Burgmans, Mark C., Meijer, T. Susanna, Martini, Christian H., Tijl, Fred G. J., Vuyk, Jaap, van Erkel, Arian R., van der Velde, Cornelis J. H., Kapiteijn, Ellen, Vahrmeijer, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554291/
https://www.ncbi.nlm.nih.gov/pubmed/28451811
http://dx.doi.org/10.1007/s00270-017-1630-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554291/
https://www.ncbi.nlm.nih.gov/pubmed/28451811
http://dx.doi.org/10.1007/s00270-017-1630-4

Ejemplares similares